Newborn Screening Awereness Month
September marks Newborn Screening Awareness Month, a time dedicated to raising awareness about the critical importance of early detection of congenital and metabolic disorders in newborns. At LaCAR MDx Technologies, we are proud to support this global initiative through our advanced screening solutions.
Why this month matters :
- Millions of newborns are screened globally within days of birth to detect rare yet serious conditions that may not be visible at birth.
- Early diagnosis can mean the difference between a healthy future and irreversible complications — or even death — if left untreated.
Our commitment at LaCAR MDx:
We offer a comprehensive range of newborn screening solutions, including:
- Immunoassay kits for conditions such as Phenylketonuria (PKU), Galactosemia, Congenital Hypothyroidism, Congenital Adrenal Hyperplasia (CAH), and Cystic Fibrosis.
- Mass spectrometry test for hemoglobinopathies screening
- DNA analysis kits for Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID).
- Digital microfluidics for Lysosomal storage disorders
- Automatic analysis & interpretation systems with NEO‑C‑500, NEO‑F‑500, SEEKER®, and our GeneFoxCub software, designed for rapid and accurate data interpretation.
This September, let’s act together:
- Educate healthcare professionals and families about the importance of newborn screening.
- Highlight the technologies that improve access and reliability of early diagnosis.
- Partner with health organizations to expand screening panels for rare but treatable diseases — as seen in recent public health updates on SMA and SCID screening programs (heraldsun.com.au).
Conclusion:
At LaCAR MDx, we believe every child deserves the best possible start in life. By raising awareness and offering cutting-edge diagnostic tools, we’re helping shape a healthier future — one newborn at a time.